Abstract:OBJECTIVE:To investigate the therapeutic effects of pulmonary surfactant (PS) on smoking-induced lung injury in rats.METHODS:Thirty male Wistar rats were randomly divided into four groups: normal control group (n = 8, killed by the end of the 7th week), 3-week smoking group (n = 8, in haling mainstream smoke of cigarette for 3 weeks and killed by the end of the 3rd week), 7-week smoking group (n = 8, in haling mainstream smoke of cigarette for 7 weeks and killed by the end of the 7th week), and PS treatment group (n = 6, inhaling mainstream smoke of cigarette for 7 weeks and given PS 25 mg/kg via trachea per week for 4 weeks since the end of the 3rd week of smoking, totally 5 times, and then killed by the end of the 7th week). The histological changes of respiratory bronchioles were observed by light microscopy and transmission electron microscopy. The airway resistance in expiratory phase was tested by pulmonary function test apparatus. The expression of Clara cell 16KD protein (CC16) mRNA and SP-C mRNA in lung tissue was determined by RT-PCR and the expression of CC16 protein in bronchiole epithelial cells was determined by immunohistochemistry.RESULTS:The proportion of Clara cell to the respiratory bronchiole epithelial cells was 62% in the normal controls, 40% in the 3-week smoking group, 33% in the 7-week smoking group, and 56% in the PS treatment group (significantly lower in comparison with that in the 7-week group, P < 0.05). Degeneration of Clara cells, hyperplasis of type II pneumocytes and increase of area of smooth muscle in bronchioles were observed in the three smoking groups, however, such changes were the most distinct in the 7-week smoking group and the less distinct in the PS treatment group (P < 0.05). In comparison with those in the normal control group, the expression of CC16 mRNA, SP-C mRNA and CC16 protein were lower in the three smoking groups. However, the expressions of CC16 mRNA and the expression of SP-C mRNA in the PS treatment group were significantly higher than those in the 7-week smoking group (11.8 +/- 5.1 vs 3.0 +/- 0.9, and 8.5 +/- 3.4 vs 2.5 +/- 0.9, both P < 0.05). The mean area of smooth muscle in bronchioles with the diameter less than 200 micro m was significantly larger than that in the control group, however, the mean area in the PS treatment group was significantly less than that in the 7-week smoking group (P < 0.05). The airway resistance in the control group (1.62 +/- 0.08 cmH(2)O. L(-1). s(-1)) was lower than those in the 3 smoking groups, however, the airway resistance in the PS treatment group was significantly lower than that in the 7-week group (1.70 +/- 0.07 cmH(2)O. L(-1). s(-1) vs 2.98 +/- 0.65 cmH(2)O. L(-1). s(-1), P < 0.05).CONCLUSION:PS is effective in alleviating smoking-induced lung injury in rats. One of the mechanisms might be attenuation of the damage in Clara cells and type II pneumocytes due to cigarette smoking.

Long-Term Sequelae of Smoking and Cessation in Spontaneously Hypertensive Rats

Effects of chronic secondhand smoke exposure on cardiovascular regulation and the role of soluble epoxide hydrolase in mice

Effect of Smoking Cessation on Airway Inflammation of Rats with Chronic Bronchitis

Chronic Toxicity of Cigarette Smoke on Rats

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties

Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats.

[Role and Mechanism of Hydrogen Sulfide in Cigarette Smoke Induced Chronic Obstructive Pulmonary Disease Related Pulmonary Vascular Remodeling in Rats].

Therapeutic Effects of Pulmonary Surfactant on Smoking-Induced Lung Injury in Rats, an Experimental Study

Effect of Cigarette Smoke on Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease in Hamster

Observations on Lung Function and Pathological Changes of Airway Lung Tissues in Rats with Different Passive-somking Durations

Losartan Attenuates Chronic Cigarette Smoke Exposure-Induced Pulmonary Arterial Hypertension in Rats: Possible Involvement of Angiotensin-Converting Enzyme-2

Effects of long-term smoking on the activity and mRNA expression of CYP isozymes in rats.

Dynamic changes in spirometry and pathology of smoke-induced chronic obstructive pulmonary disease rat

Resveratrol Attenuates Left Ventricular Remodeling in Old Rats with COPD Induced by Cigarette Smoke Exposure and LPS Instillation

Sex Dependent Occlusive Cardiovascular Disease Effects of Short-Term Thirdhand Smoke Exposure

Chronic cigarette smoke exposure triggers a vicious cycle of leukocyte and endothelial-mediated oxidant stress that results in vascular dysfunction

Hydrogen-rich Saline Inhibits Tobacco Smoke-Induced Chronic Obstructive Pulmonary Disease by Alleviating Airway Inflammation and Mucus Hypersecretion in Rats.

Exposure to Cigarette Smoke Downregulatesβ2-Adrenergic Receptor Expression and Upregulates Inflammation in Alveolar Macrophages

Biomarkers of disease can be detected in mice as early as 4 weeks after initiation of exposure to third-hand smoke levels equivalent to those found in homes of smokers

Inhibitory Effects of Hydrogen Sulphide on Pulmonary Fibrosis in Smoking Rats Via Attenuation of Oxidative Stress and Inflammation

Adverse Health Effects of Thirdhand Smoke: from Cell to Animal Models